Title |
Inhibition of basal and ultraviolet B-induced melanogenesis by cannabinoid CB1 receptors: a keratinocyte-dependent effect
|
---|---|
Published in |
Archives of Dermatological Research, February 2011
|
DOI | 10.1007/s00403-011-1126-z |
Pubmed ID | |
Authors |
Sofia Magina, Carina Esteves-Pinto, Eduardo Moura, Maria Paula Serrão, Daniel Moura, Stefania Petrosino, Vincenzo Di Marzo, Maria Augusta Vieira-Coelho |
Abstract |
Ultraviolet radiation is the major environmental insult to the skin and stimulates the synthesis of melanin in melanocytes, which then distribute it to the neighboring keratinocytes where it confers photo-protection. Skin color results from the paracrine interaction between these two cell types. Recent studies suggest that endocannabinoids are potential mediators in the skin. Here, we investigated whether cannabinoid drugs play a role in melanogenesis and if ultraviolet radiation modifies the cutaneous endocannabinoid system. We used human melanotic melanoma cell line (SK-mel-1) in monoculture or co-culture with human keratinocytes (HaCat). Endocannabinoid levels, cannabinoid receptors expression, and melanin content were evaluated under basal conditions and after ultraviolet-B irradiation (311 nm). We provide evidence that human melanoma cells (SK-mel-1) express CB(1) receptors, and when in co-culture with keratinocytes (HaCat), the selective CB(1) receptor agonist arachidonyl-2-chloroethylamide (ACEA 1 and 10 μM) inhibited (by 33.4 and 37.3%, respectively) basal melanogenesis. In addition, ultraviolet-B-induced melanogenesis in co-cultures was abolished by ACEA 10 μM. Both ACEA inhibitory effects were reversed by AM251 (1 μM), a selective CB(1) antagonist. Furthermore, ultraviolet-B radiation increased endocannabinoids levels only in keratinocytes, whereas CB(1) cannabinoid receptor expression was up-regulated only in melanoma cells. Our results collectively suggest that ultraviolet radiation activates paracrine CB(1)-mediated endocannabinoid signaling to negatively regulate melanin synthesis. The endocannabinoid system in the skin may be a possible target for future therapies in pigmentary disorders. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 2% |
United States | 1 | 2% |
Unknown | 40 | 95% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 11 | 26% |
Student > Bachelor | 6 | 14% |
Student > Doctoral Student | 5 | 12% |
Researcher | 4 | 10% |
Student > Ph. D. Student | 3 | 7% |
Other | 5 | 12% |
Unknown | 8 | 19% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 12 | 29% |
Medicine and Dentistry | 6 | 14% |
Pharmacology, Toxicology and Pharmaceutical Science | 4 | 10% |
Biochemistry, Genetics and Molecular Biology | 4 | 10% |
Immunology and Microbiology | 2 | 5% |
Other | 4 | 10% |
Unknown | 10 | 24% |